Head Position Matters in Stroke Care Before Thrombectomy
A flat 0° head positioning before thrombectomy was associated with a significantly less risk for early neurologic deterioration and all-cause mortality than a conventional 30° head elevation in adults with large vessel occlusion (LVO) stroke, a new study showed.
METHODOLOGY:
Researchers conducted the prospective, multicenter ZODIAC trial from 2018 to 2023 with 92 patients (mean age, 67 years; 52% men). All had LVO stroke confirmed on CT angiography and a viable penumbra and were eligible for thrombectomy within 24 hours of stroke.
Participants were randomly assigned to receive either 0° (n = 45) or 30° (n = 47) head-of-bed positioning before thrombectomy.
National Institutes of Health Stroke Scale (NIHSS) scores were assessed every 10 minutes until thrombectomy began.
The primary endpoint was early neurologic deterioration, defined as a worsening of ≥ 2 NIHSS points before thrombectomy. Additional outcomes were severe neurologic deterioration (worsening of ≥ 4 NIHSS points) before thrombectomy, hospital-acquired pneumonia, and all-cause death within 3 months.
TAKEAWAY:
Early neurologic deterioration was more common in the 30° group than in the 0° group (55% vs 2%; hazard ratio [HR], 34.4; P < .001), as was severe neurologic deterioration (n = 20 vs n = 1; HR, 23.6; P = .002).
< .001), as was severe neurologic deterioration (n = 20 vs n = 1; HR, 23.6; = .002). The all-cause mortality rate at 90 days was significantly lower in the 0° group than in the 30° group (4% vs 22%; P = .03).
= .03). A greater proportion of patients in the 0° group than in the 30° group showed neurologic improvement at 24 hours post-thrombectomy (87% vs 60%; odds ratio, 0.2; P = .01).
= .01). No participant in either group developed hospital-acquired pneumonia.
IN PRACTICE:
'Results suggest that patients awaiting thrombectomy treatment for LVO stroke should be positioned with the head at 0° to ensure clinical stability and prevent worsening,' the investigators wrote.
'We posit that 0° head positioning is a bridging maneuver to thrombectomy, protecting ischemic tissue and possibly reducing infarct progression before definitive treatment,' they added.
SOURCE:
This study was led by Anne W. Alexandrov, PhD, University of Tennessee Health Science Center, Memphis, Tennessee. It was published online on June 04 in JAMA Neurology .
LIMITATIONS:
This study was limited by its small sample size and early termination, the lack of blinding to head position, and the exclusion of data on thrombectomy decisions. Additionally, patients transferred between facilities were excluded, which may have affected the 3-month outcomes.
DISCLOSURES:
Funding was provided by the NIH. Several investigators reported receiving a grant or per-patient payment from NIH during the study. One also reported being a paid co-investigator on the NIH grant for imaging core lab services. Full details are listed in the original article.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
18 minutes ago
- Medscape
The Longevity Paradox: Medicine Meets Silicon Valley
'For without friends, no one would choose to live.' - Aristotle Jeffrey Benabio, MD, MBA Last year, Bryan Johnson, a 46-year-old tech founder, spent 2 million dollars on a regimen that included monthly plasma transfusions from his teenage son. Why? Well, we live in an age when the wealthy inject themselves with young blood, undergo elaborate hormone replacement protocols, get infusions of NAD+, and gobble metformin pill-packs to optimize their biological age. The sell is seductive: Death is evitable. Aging is curable. And with enough money, one can live to be old and healthy. The venture capital bets might be recent, but the yearning is ancient. Herodotus wrote in the 5th century BCE about special waters the long-lived Macrobians drank and bathed in — waters that not only extended life but left their skin "glossy and smooth." Later, Alexander the Great, in his conquests, was said to have been on a quest to find the "Water of Life." He died at 32, which is probably why his product isn't a popular supplement on Amazon today. Lucas Cranach's "The Fountain of Youth," painted in the late Medieval period, shows old and infirm patrons swimming in magical waters and emerging vibrant and young on the other side. Perhaps those waters had rapamycin-producing Streptomyces growing in it — which is a top seller today. The Fountain of Youth by Lucas Cranach d.Ä. Behind the tempting pitch to live forever lies an uncomfortable question: Is this medicine? Should we be testing testosterone on an athletic 23-year-old? Or continuously monitor glucose for a healthy adult with no signs of diabetes? Few doctors would order these for patients, and fewer payors would pick up the tab if they were ordered. This is the disconnect between medicine and entrepreneurs. "The medical system is so patronizing," said a young venture capitalist on a popular startup podcast I was listening to. He was complaining about how doctors resist ordering MRIs or specialized tests because we doctors "think patients are idiots." We do not. He's missing the point that, as a healthy 30-something, medicine is not resourced to help him with wellness requests. Who should pay for his requested MRI? Who would interpret the results? We physicians cannot keep up with the demand for services from those who need us acutely. We've no plan for absorbing a new generation of the "worried well" — better named the "ambitious well" — while also caring for their boomer grandparents. We have a critical shortage of primary care physicians; one that will only worsen as our population ages. The Association of American Medical Colleges projects a shortage of up to 40,400 primary care doctors by 2036. What happens if a portion of that workforce begins dedicating their time to monitoring biomarkers and fine-tuning supplement regimens for patients who are not sick? Healthcare resources — physicians' time, diagnostic equipment, laboratory services — are finite. Every hour we spend with a healthy person seeking optimization is an hour not spent with a patient who is ill. For every primary care physician giving up their practice for a cash-paying longevity clinic, there will be 2000 or so patients who now have to be redistributed onto already burdened practices. When healthy 35-year-olds can get same-day MRIs at boutique practices while my father-in-law waits nearly 2 months for an MRI to characterize a renal mass seen on ultrasound, we've failed. Caring for cash-paying patients who can sit with you for an hour is preferable to the daily grind of 15-minute appointments for patients who actually need an hour of your time. Why shouldn't docs get to choose? For one thing, our training is publicly funded. Taxpayer dollars pick up the tab for more than $20 billion in graduate medical education every year. It seems not quite right that this education doesn't at least in part serve the public who funded it. Despite these concerns, we should acknowledge the import of the longevity movement. Prevention is indeed better than cure. Early intervention can avert costly medical problems. And individuals have a right to pursue health optimizations they value, using their own resources. The question is, how should longevity medicine relate to our broader healthcare system and societal priorities? I think transparency is essential. Longevity interventions should be clearly labeled based on the strength of supporting research. It's the standard we adhere to every day in practice. We also need to be clearer about necessity versus enhancement. Insurance coverage and public resources should prioritize interventions that address or prevent disease. Enhancement services should be demarcated as distinct from necessary medical care. Physicians working in longevity medicine might also acknowledge some societal obligations. Perhaps consider devoting a portion of their practice to underserved populations or contributing to research that benefits the broader public, not just those who can afford boutique services. We also surely must address the structural factors that push physicians toward concierge practices. If doctors are fleeing due to administrative burden and time constraints, improving those would help ensure care remains accessible to all. Lastly, we might recognize that the best determinants of longevity operate at the population not the individual level. Clean air and water, safe neighborhoods, access to nutritious food, and strong social connections likely do more to improve the health and longevity of a population than any supplement or monitoring device. Realizing the promise of longevity medicine requires more than scientific breakthrough; it demands clarity about how these advances should be distributed and what values should guide their application. As physicians we face a choice: Should we allow longevity to become another domain where privilege determines outcomes? Or could we build a system where the benefits of extended healthy life are available to all? Since Herodotus and after nearly 2500 years of searching, we still haven't found the water of life. Or maybe Aristotle actually discovered it just a few years later: gymnastics, moderation in food and drink, and good friends. It's hard to raise a series A with that pitch though.
Medscape
24 minutes ago
- Medscape
Fast Five Quiz: The Presentation and Diagnosis of LOPD
In LOPD, respiratory muscle involvement, particularly diaphragmatic weakness, can be an early manifestation. This can include symptoms such as exertional dyspnea, orthopnea, and sleep-disordered breathing. Recognizing these signs is crucial, as they might precede limb-girdle muscle weakness, providing an opportunity for early diagnosis and treatment. Other respiratory symptoms, such as chronic cough with sputum production, wheezing that is responsive to bronchodilators, or hemoptysis associated with pulmonary embolism, are not as likely characteristic of LOPD and more likely suggest alternative diagnoses, such COPD, asthma, or pulmonary infarction, respectively. Learn more about respiratory involvement in LOPD. A recent systematic review reported that patients with Pompe disease have lower GAA activity in skeletal muscles than healthy patients. More specifically, researchers found there is significantly lower GAA activity in patients with IOPD compared to those with LOPD. As a result of the lower GAA activity, patients with IOPD tend to accumulate more glycogen in the skeletal muscles and have higher glycogen content levels than those with LOPD. Learn more about the presentation of LOPD. Editor's Note: This article was created using several editorial tools, including generative AI models, as part of the process. Human review and editing of this content were performed prior to publication. Lead image: UCSF/Science Source
Health Line
33 minutes ago
- Health Line
What's the Difference Between Seborrheic Keratosis and Actinic Keratosis?
Actinic keratosis and seborrheic keratosis are two skin conditions that often show up around middle age. Since actinic keratosis lesions can become cancerous, it's best to get prompt treatment. Keratosis refers to an overgrowth of the protein keratin in the skin. This excess keratin can appear in skin lesions that resemble patches, warts, or moles. These two conditions may have similar names, but there's one major difference between the two: Actinic keratosis can become cancerous, while seborrheic keratosis cannot. This makes it important to know how to tell these lesions apart. If you have a hard time recognizing the difference between the two, here's a quick rundown: Actinic keratosis lesions often appear as rough, scaly patches that may show up in clusters. You'll often notice these patches in areas that get a lot of sun exposure, like your arms, hands, or face. Seborrheic keratosis tends to show up as a single lesion. These growths tend to be small, oval, thick, and raised. They can have a mole- or wart-like appearance. Learn more about these two conditions, along with a few key signs you may want to connect with a dermatologist for diagnosis and treatment. Actinic keratosis Since actinic keratosis is considered precancerous, it's important to identify and treat it. Signs and symptoms Actinic keratosis lesions: may appear as thick, rough, or crusty patches; sometimes, you might feel the change in skin texture rather than see it are usually smaller than 2 centimeters (cm) often appear on body parts that get a lot of sun (like your face, neck, scalp, arms, or hands) often appear as the same color as surrounding skin, if you have darker skin may appear pink on lighter skin, or have a tan, brown or gray hue might burn or itch may show up as a horn-like growth can appear as scaly or colorless patches on your lips Causes Actinic keratosis usually develops as a result of sun exposure over time. Your chances of developing this skin condition increase if you: are 50 or older have light skin and eyes tend to sunburn easily have a history of frequent sun exposure or tanning bed use have a weakened immune system Treatment options In the early stages, actinic keratosis is very treatable. Your options for treatment include: Electrocauterization: Electrocauterization involves burning the lesion with an electric current, which kills the affected skin cells. Cryotherapy: Also called cryosurgery, this treatment involves applying a solution like liquid nitrogen to the affected area. This process freezes and kills the cells so the lesion scabs and falls off. Curettage: This procedure involves scraping off the growth with a curette (a specialized surgical instrument). A dermatologist may recommend this in combination with electrosurgery. Chemical peels: A dermatologist may apply a medical-grade chemical peel in-office to help remove the top layers of affected skin. Topical medical therapy: Treatments like 5-fluorouracil can inflame and destroy the lesions. Photodynamic therapy: This treatment involves the application of a photosensitive prescription medication solution (such as aminolevulinic acid) to the affected area. A dermatologist will then direct a red or blue laser light over the treated area to help destroy the actinic keratosis cells. Seborrheic keratosis These skin lesions are the most common form of benign lesion. If you notice them on your body, you might think they're just another mole or wart. In some cases, though, they can resemble precancerous or cancerous growths, such as melanoma. Here's how to recognize this type of skin growth. Signs and symptoms Seborrheic keratosis lesions: may appear as round or oval-shaped, slightly raised growths may seem 'stuck on' to your skin often have a waxy or scale-like texture generally show up on the face, chest, back, stomach, or shoulders typically won't appear on the palms of your hands or the soles of your feet often grow larger and thicker over time and can reach about 1 inch in diameter often appear brown, black, white, or tan on light or dark skin may cause itchiness or irritation, though these lesions usually aren't painful Causes Researchers still don't know exactly what causes seborrheic keratoses. The lesions don't seem to be viral, bacterial, or contagious. That said, the following risk factors may increase your chances of developing these growths: Age: Seborrheic keratosis is uncommon in people under age 20. It often shows up in middle age, and more lesions may appear as you get older. Family history: They seems to run in families — the more relatives you have with these lesions, the more likely you may develop them yourself. Pregnancy or hormone therapy: Seborrheic keratoses may appear during pregnancy or estrogen replacement therapy. Frequent sun exposure: Some evidence suggests these lesions may appear more often on sun-exposed skin, but they can also develop on skin not regularly exposed to sun. Lighter skin: These lesions more commonly affect people with lighter skin, but it's possible to still get them if you have darker skin. Treatment options Seborrheic keratosis often doesn't require treatment. But if you dislike the way your lesion looks or feels, you can always speak with a dermatologist or other doctor about removal. If your lesion is actually a precancerous or cancerous growth, you'll need to have it removed. Your healthcare professional may recommend one of these procedures: Cryosurgery Electrosurgery and curettage Shave excision: Your dermatologist may shave off a sample of the growth to send it to a lab for analysis. Ablation: This procedure involves using a specialized laser to vaporize the growth. Nitric acid-zinc solution: This treatment involves using a topical solution called nitrizinc complex. Emerging evidence suggests this treatment can safely shrink or totally eliminate the lesion, often within about 6 months. When to get medical help Any time your skin changes unexpectedly or you're concerned about a lesion, a good next step involves getting an assessment from a dermatologist or other medical professional. Since actinic keratosis can sometimes turn into skin cancer, being vigilant about check-ups can help you lower your risk of skin cancer. And even though seborrheic keratosis may not pose any danger to your health, it never hurts to have a professional confirm that your skin growth isn't cancerous. As a general rule, you'll want to have a healthcare professional inspect your skin if: You have a new growth. The appearance of an existing growth changes. A growth appears purple, blue or reddish or changes colors. A growth has blurred or irregular borders. A growth irritates you, bleeds, or causes pain. Prevention tips Frequent sun exposure can increase your chances of skin cancer, but these tips can help lower your risk: Wear sunscreen every day — rain or shine, indoors or out. Opt for sunscreen that has a SPF rating of at least 30, with broad spectrum protection to block both UVA and UVB rays. Avoid tanning beds. Avoid spending time outside between 10 a.m. and 4 p.m. UV rays are strongest in the middle of the day. Protect your skin from UV rays by wearing hats, long sleeves, and pants. Bottom line Both actinic keratosis and seborrheic keratosis are skin conditions that show up as growths. Since actinic keratosis lesions can potentially become cancerous, it helps to know how to tell the difference between the two. Seborrheic keratosis are raised lesions that tend to have a round or oval shape, while actinic keratosis typically shows up as dry patches in areas of skin that get frequent sun exposure.
